Experimental and computational models to investigate intestinal drug permeability and metabolism-Reference-Cited by-同舟云学术

Experimental and computational models to investigate intestinal drug permeability and metabolism

Published:2023-01-02 Issue:1 Volume:53 Page:25-45
ISSN:0049-8254
Container-title:Xenobiotica
language:en
Short-container-title:Xenobiotica

Author:

Chen Jinyuan¹²,Yuan Ziyun³,Tu Yifan⁴,Hu Wanyu³,Xie Cong⁵,Ye Ling²

Affiliation:

1. Institute of Scientific Research, Southern Medical University, Guangzhou, P.R. China

2. TCM-Integrated Hospital, Southern Medical University, Guangzhou, P.R. China

3. NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, P.R. China

4. Boehringer-Ingelheim, Connecticut, P.R. USA

5. Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou, P.R. China

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,Biochemistry,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00498254.2023.2180454

Reference201 articles.

1. Reviewing Data Integrated for PBPK Model Development to Predict Metabolic Drug-Drug Interactions: Shifting Perspectives and Emerging Trends

2. Predicting the impact of physiological and biochemical processes on oral drug bioavailability

3. Ultrasensitive Quantification of Drug-metabolizing Enzymes and Transporters in Small Sample Volume by Microflow LC-MS/MS

4. In vitro and in vivo performance modelling and optimisation of different dry powder inhalers: A complementary study of neural networks, genetic algorithms and decision trees

5. In silicoADME-Tox modeling: progress and prospects

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral Absorption of Middle-to-Large Molecules and Its Improvement, with a Focus on New Modality Drugs;Pharmaceutics;2023-12-28

2. Decreased Penetration Mechanism of Ranitidine Due to Application of Sodium Sulfobutyl Ether-β-Cyclodextrin;Pharmaceutics;2023-11-06